Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Assessing Safety, Hospitalization and Efficacy of rNAPc2 in COVID-19 (ASPEN-COVID-19)

NCT04655586 is registered in ClinicalTrials.gov with ARCA Biopharma, Inc. as lead sponsor.

NCT NCT04655586
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04655586 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Assessing Safety, Hospitalization and Efficacy of rNAPc2 in COVID-19 (ASPEN-COVID-19)
Lead sponsor
ARCA Biopharma, Inc.
Phase
Phase 2/3
Overall status
Completed
Start date
December 10, 2020
Completion date
March 7, 2022
Enrollment
160 (actual)
Sites
24

Conditions

As the registry lists them; a condition with its own page is linked.

covid19